mutLBSgeneDB |
Gene summary for RB1 |
Gene summary |
Basic gene Info. | Gene symbol | RB1 |
Gene name | retinoblastoma 1 | |
Synonyms | OSRC|PPP1R130|RB|p105-Rb|pRb|pp110 | |
Cytomap | UCSC genome browser: 13q14.2 | |
Type of gene | protein-coding | |
RefGenes | NM_000321.2, | |
Description | prepro-retinoblastoma-associated proteinprotein phosphatase 1, regulatory subunit 130retinoblastoma suspectibility proteinretinoblastoma-associated protein | |
Modification date | 20141219 | |
dbXrefs | MIM : 614041 | |
HGNC : HGNC | ||
Ensembl : ENSG00000139687 | ||
HPRD : 01574 | ||
Vega : OTTHUMG00000016900 | ||
Protein | UniProt: P06400 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_RB1 | |
BioGPS: 5925 | ||
Pathway | NCI Pathway Interaction Database: RB1 | |
KEGG: RB1 | ||
REACTOME: RB1 | ||
Pathway Commons: RB1 | ||
Context | iHOP: RB1 | |
ligand binding site mutation search in PubMed: RB1 | ||
UCL Cancer Institute: RB1 | ||
Assigned class in mutLBSgeneDB | A: This gene has a literature evidence and it belongs to targetable_mutLBSgenes. | |
References showing study about ligand binding site mutation for RB1. | 1. "Baillie RA, Sha X, Thuillier P, Clarke SD. A novel 3T3-L1 preadipocyte variant that expresses PPARgamma2 and RXRalpha but does not undergo differentiation. J Lipid Res. 1998 Oct;39(10):2048-53." 9788251 |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0043550 | regulation of lipid kinase activity | 16286473 | GO:0045892 | negative regulation of transcription, DNA-templated | 10783144 |
Top |
Ligand binding site mutations for RB1 |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | N716,K720 | D718G | COAD | 4 | E533 | E533G | COAD | 3 | N716,V714 | K715E | COAD | 2 | H555 | R556Q | COAD | 2 | Y756 | Y756C | COAD | 2 | M761 | M761L | BLCA | 1 | E551 | L550I | BRCA | 1 | N716,K720 | D718N | COAD | 1 | I66 | K65N | COAD | 1 | L660 | Y659H | COAD | 1 | L660 | R661W | COAD | 1 | H555 | R556L | COAD | 1 | N716,V714 | K715R | COAD | 1 | L660 | R661L | COAD | 1 | L660 | Y659F | GBM | 1 | K653 | V654L | GBM | 1 | L660 | R661W | GBM | 1 | K653 | V654M | KIRC | 1 | Y756 | Y756C | LUAD | 1 | I66 | D68G | LUSC | 1 | M761,K765 | R763T | OV | 1 | M460 | L461P | SKCM | 1 | Y756 | F755I | UCEC | 1 | N757 | S758L | UCEC | 1 | I752 | S751Y | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Clinical information for RB1 from My Cancer Genome. |
Retinoblastoma 1 (RB1) is a gene that encodes a protein that is a negative regulator of the cell cycle as well as a tumor suppressor. Missense mutations, nonsense mutations, silent mutations, frameshift deletions and insertions, and in-frame deletions are observed in cancers such as cancers of the fallopian tubes, cancers of the eye, and intestinal cancer.Related Pathways: Cell cycle control.Modified: December 4, 2015 |
Top |
Protein structure related information for RB1 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | N757 | S758L | 0.016335882 | E533 | E533G | -1.5622795 | K720 | D718G | -1.4526905 | N716 | D718G | -1.4526905 | M460 | L461P | -1.3971126 | I66 | D68G | -1.3286123 | K720 | D718N | -1.3272052 | N716 | D718N | -1.3272052 | M761 | R763T | -1.3259044 | K765 | R763T | -1.3259044 | I66 | K65N | -1.2897835 | L660 | Y659H | -1.0313084 | Y756 | F755I | -1.0067972 | K653 | V654M | -0.92793829 | L660 | R661W | -0.90906764 | H555 | R556Q | -0.89148432 | V714 | K715R | -0.82529546 | N716 | K715R | -0.82529546 | N716 | K715E | -0.78224004 | V714 | K715E | -0.78224004 | Y756 | Y756C | -0.69245694 | K653 | V654L | -0.69093928 | I752 | S751Y | -0.6822503 | L660 | R661L | -0.67768182 | L660 | Y659F | -0.61288987 | E551 | L550I | -0.51137438 | H555 | R556L | -0.35363539 | M761 | M761L | -0.098350003 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for RB1 from PDB |
PDB ID | PDB title | PDB structure | 1AD6 | DOMAIN A OF HUMAN RETINOBLASTOMA TUMOR SUPPRESSOR |
Top |
Differential gene expression and gene-gene network for RB1 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
RB1_COAD_DE |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
* In COAD | |
Top |
Top |
Phenotype information for RB1 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C0035335 | Retinoblastoma | 273 | AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification |
umls:C0029463 | Osteosarcoma | 41 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0007097 | Carcinoma | 40 | AlteredExpression, Biomarker, GeneticVariation |
umls:C2239176 | Carcinoma, Hepatocellular | 23 | Biomarker, GeneticVariation, PostTranslationalModification |
umls:C0149925 | Small Cell Lung Carcinoma | 19 | AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification |
umls:C1458155 | Breast Neoplasms | 17 | AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification |
umls:C0005684 | Malignant neoplasm of bladder | 12 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0007131 | Carcinoma, Non-Small-Cell Lung | 9 | AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification |
umls:C0080113 | Retinoblastoma Protein | 9 | GeneticVariation |
umls:C0005695 | Urinary Bladder Neoplasms | 6 | AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification |
umls:C0279626 | Esophageal Squamous Cell Carcinoma | 6 | AlteredExpression, Biomarker, GeneticVariation |
umls:C1961102 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0030297 | Pancreatic Neoplasms | 3 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0206686 | Adrenocortical Carcinoma | 2 | Biomarker |
umls:C0001624 | Adrenal Gland Neoplasms | 1 | Biomarker |
umls:C0007786 | Brain Ischemia | 1 | Biomarker |
umls:C0017661 | Glomerulonephritis, IGA | 1 | Biomarker |
umls:C0023904 | Liver Neoplasms, Experimental | 1 | Biomarker |
umls:C0024667 | Mammary Neoplasms, Animal | 1 | Biomarker |
umls:C0024668 | Mammary Neoplasms, Experimental | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
28126 | R661W | Pathogenic | Germline;somatic | GeneReviews:NBK1452 MedGen:C0035335 OMIM:180200 Orphanet:ORPHA790 MedGen:CN221809 |
106668 | V654M | Likely pathogenic;Uncertain significance | Somatic | MedGen:CN221809 |
Top |
Pharmacological information for RB1 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Gene-centered drug-gene interaction network |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Approved|investigational | DB00030 | Insulin Human | Biotech | |
Approved | DB00071 | Insulin Pork | Biotech |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of RB1 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | III | Peptide ligand (LEU,ASP,TYR,HIS,PHE,GLY,LEU,GLU,GLU,GLY,GLU,GLY,ILE,ARG,ASP,LEU,PHE,ASP) | 1o9k | A | E533 | III | Peptide ligand (LEU,ASP,TYR,HIS,PHE,GLY,LEU,GLU,GLU,GLY,GLU,GLY,ILE,ARG,ASP,LEU,PHE,ASP) | 1o9k | C | E533 E551 | III | Peptide ligand (LEU,ASP,TYR,HIS,PHE,GLY,LEU,GLU,GLU,GLY,GLU,GLY,ILE,ARG,ASP,LEU,PHE,ASP) | 1o9k | E | E533 E551 | III | Peptide ligand (LEU,ASP,TYR,HIS,PHE,GLY,LEU,GLU,GLU,GLY,GLU,GLY,ILE,ARG,ASP,LEU,PHE,ASP) | 1o9k | G | E533 E551 | III | Peptide ligand (ASP,ASP,TYR,LEU,TRP,GLY,LEU,GLU,ALA,GLY,GLU,GLY,ILE,SER,ASP,LEU,PHE,ASP) | 1n4m | A | E533 E551 H555 K653 L660 | III | Peptide ligand (LEU,ASP,TYR,HIS,PHE,GLY,LEU,GLU,GLU,GLY,GLU,GLY,ILE,ARG,ASP,LEU,PHE,ASP) | 1o9k | B | K653 | III | Peptide ligand (LEU,ASP,TYR,HIS,PHE,GLY,LEU,GLU,GLU,GLY,GLU,GLY,ILE,ARG,ASP,LEU,PHE,ASP) | 1o9k | D | K653 | III | Peptide ligand (LEU,ASP,TYR,HIS,PHE,GLY,LEU,GLU,GLU,GLY,GLU,GLY,ILE,ARG,ASP,LEU,PHE,ASP) | 1o9k | F | K653 | III | Peptide ligand (LEU,ASP,TYR,HIS,PHE,GLY,LEU,GLU,GLU,GLY,GLU,GLY,ILE,ARG,ASP,LEU,PHE,ASP) | 1o9k | H | K653 | III | Peptide ligand (PRO,PRO,THR,LEU,HIS,GLU,LEU,TYR,ASP,LEU) | 2r7g | A | M460 E533 | III | Peptide ligand (PRO,PRO,THR,LEU,HIS,GLU,LEU,TYR,ASP,LEU) | 2r7g | C | M460 E533 | III | Peptide ligand (ASP,ASP,TYR,LEU,TRP,GLY,LEU,GLU,ALA,GLY,GLU,GLY,ILE,SER,ASP,LEU,PHE,ASP) | 1n4m | B | M460 E533 E551 H555 K653 L660 | III | Peptide ligand (ASP,LEU,TYR,CYS,TYR,GLU,GLN,LEU,ASN) | 1gux | B | V714 K720 I752 Y756 N757 M761 K765 | III | Peptide ligand (PRO,PRO,THR,LEU,HIS,GLU,LEU,TYR,ASP) | 2r7g | A | V714 K720 Y756 N757 M761 | III | Peptide ligand (ASP,ASP,TYR,LEU,TRP,GLY,LEU,GLU,ALA,GLY,GLU,GLY) | 1n4m | B | V714 N716 Y756 N757 M761 K765 |
Top |
Conservation information for LBS of RB1 |
Multiple alignments for P06400 in multiple species |
LBS | AA sequence | # species | Species | A772 | NILQYASTRPP | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | A772 | NILQYASNRPP | 1 | Gallus gallus | D479 | SKLLNDNIFHM | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | D479 | SKLLNDNIFHT | 1 | Gallus gallus | E464 | SMLKSEEERLS | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | E533 | FYKVIESFIKV | 3 | Gallus gallus, Mus musculus, Rattus norvegicus | E533 | FYKVIESFIKA | 1 | Homo sapiens | E551 | MIKHLERCEHR | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | E554 | HLERCEHRIME | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | F482 | LNDNIFHMSLL | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | F482 | LNDNIFHTSLL | 1 | Gallus gallus | F721 | NIDLKFKIIVT | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | F721 | NVDLRFKTIVS | 1 | Gallus gallus | H555 | LERCEHRIMES | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | I470 | EERLSIQNFSK | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | I470 | EERLSVHNFSK | 1 | Gallus gallus | I481 | LLNDNIFHMSL | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | I481 | LLNDNIFHTSL | 1 | Gallus gallus | I536 | VIESFIKVEAN | 2 | Mus musculus, Rattus norvegicus | I536 | VIESFIKAEGN | 1 | Homo sapiens | I536 | VIESFIKVEPS | 1 | Gallus gallus | I66 | CQKLKVPDHVR | 2 | Mus musculus, Rattus norvegicus | I66 | CQKLKIPDHVR | 1 | Homo sapiens | I66 | CDALKAPDSVR | 1 | Gallus gallus | I752 | EEFDSIIVFYN | 2 | Mus musculus, Rattus norvegicus | I752 | EEYDSIIVFYN | 1 | Homo sapiens | I752 | EQYDSIIVFYN | 1 | Gallus gallus | I753 | EFDSIIVFYNS | 2 | Mus musculus, Rattus norvegicus | I753 | EYDSIIVFYNS | 1 | Homo sapiens | I753 | QYDSIIVFYNL | 1 | Gallus gallus | I768 | RLKTNILQYAS | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | I768 | KLKTNILQYAS | 1 | Gallus gallus | K475 | IQNFSKLLNDN | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | K475 | VHNFSKLLNDN | 1 | Gallus gallus | K530 | AFDFYKVIESF | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | K537 | IESFIKVEANL | 2 | Mus musculus, Rattus norvegicus | K537 | IESFIKAEGNL | 1 | Homo sapiens | K537 | IESFIKVEPSL | 1 | Gallus gallus | K548 | TREMIKHLERC | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | K548 | TRDMIKHLERC | 1 | Gallus gallus | K652 | LSLFYKKVYRL | 2 | Homo sapiens, Rattus norvegicus | K652 | LSLFYKKVFRL | 1 | Gallus gallus | K652 | LALFYKKVYRL | 1 | Mus musculus | K653 | SLFYKKVYRLA | 2 | Homo sapiens, Rattus norvegicus | K653 | SLFYKKVFRLA | 1 | Gallus gallus | K653 | ALFYKKVYRLA | 1 | Mus musculus | K713 | MYGICKVKNID | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | K713 | MYGICKVKNVD | 1 | Gallus gallus | K720 | KNIDLKFKIIV | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | K720 | KNVDLRFKTIV | 1 | Gallus gallus | K722 | IDLKFKIIVTA | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | K722 | VDLRFKTIVSA | 1 | Gallus gallus | K765 | FMQRLKTNILQ | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | K765 | FMQKLKTNILQ | 1 | Gallus gallus | L468 | SEEERLSIQNF | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | L468 | SEEERLSVHNF | 1 | Gallus gallus | L476 | QNFSKLLNDNI | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | L476 | HNFSKLLNDNI | 1 | Gallus gallus | L649 | STSLSLFYKKV | 3 | Homo sapiens, Gallus gallus, Rattus norvegicus | L649 | STSLALFYKKV | 1 | Mus musculus | L660 | YRLAYLRLNTL | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | L660 | FRLAYLRLHTL | 1 | Gallus gallus | L769 | LKTNILQYAST | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | L769 | LKTNILQYASN | 1 | Gallus gallus | M460 | RVMESMLKSEE | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | M761 | YNSVFMQRLKT | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | M761 | YNLVFMQKLKT | 1 | Gallus gallus | N472 | RLSIQNFSKLL | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | N472 | RLSVHNFSKLL | 1 | Gallus gallus | N716 | ICKVKNIDLKF | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | N716 | ICKVKNVDLRF | 1 | Gallus gallus | N757 | IIVFYNSVFMQ | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | N757 | IIVFYNLVFMQ | 1 | Gallus gallus | R467 | KSEEERLSIQN | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | R467 | KSEEERLSVHN | 1 | Gallus gallus | R656 | YKKVYRLAYLR | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | R656 | YKKVFRLAYLR | 1 | Gallus gallus | R775 | QYASTRPPTLS | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | R775 | QYASNRPPTLS | 1 | Gallus gallus | S534 | YKVIESFIKVE | 3 | Gallus gallus, Mus musculus, Rattus norvegicus | S534 | YKVIESFIKAE | 1 | Homo sapiens | S644 | QKPLKSTSLSL | 2 | Homo sapiens, Rattus norvegicus | S644 | QKPQKSTSLSL | 1 | Gallus gallus | S644 | QKPLKSTSLAL | 1 | Mus musculus | S646 | PLKSTSLSLFY | 2 | Homo sapiens, Rattus norvegicus | S646 | PQKSTSLSLFY | 1 | Gallus gallus | S646 | PLKSTSLALFY | 1 | Mus musculus | S773 | ILQYASTRPPT | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | S773 | ILQYASNRPPT | 1 | Gallus gallus | T645 | KPLKSTSLSLF | 2 | Homo sapiens, Rattus norvegicus | T645 | KPQKSTSLSLF | 1 | Gallus gallus | T645 | KPLKSTSLALF | 1 | Mus musculus | T774 | LQYASTRPPTL | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | T774 | LQYASNRPPTL | 1 | Gallus gallus | V531 | FDFYKVIESFI | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | V714 | YGICKVKNIDL | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | V714 | YGICKVKNVDL | 1 | Gallus gallus | Y709 | MMCSMYGICKV | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | Y756 | SIIVFYNSVFM | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | Y756 | SIIVFYNLVFM | 1 | Gallus gallus |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |